InspireMD, Inc. — Form 8-K
Filed November 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
InspireMD, Inc. (market cap ~$60.9M) executed an underwriting agreement dated November 13, 2026 with Lake Street Capital Markets as representative. The company issued 7.34M shares at $0.611/share, 50.35M pre-funded warrants at $0.6109/warrant, and 43.27M common warrants at $0.65 exercise price, with an optional 15% greenshoe. Firm proceeds: ~$4.75M from 7.34M shares + pre-funded warrants; underwriters receive underwriting discounts embedded in pricing. Lock-up 60 days (common); Variable Rate Transaction restriction 6 months. Closing: November 16, 2026.
Why this rating
Capital raise ~7.8% of market cap; routine equity offering for small-cap biotech. Dilutive but standard financing. No material business change disclosed.
See more from November 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.